Finance

Beta
Lists
EXPO:NASDAQ
Exponent Inc
$59.77
+1.01%
(+0.60) 1D
Jun 5, 1:20:54 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EXPO...
Open
$59.53
High
$60.34
Low
$59.03
Mkt. cap
2.90B
Avg. vol.
545.97K
Volume
205.69K
Dividend
2.07%
Quarterly dividend
$0.31
Ex-dividend date
Jun 5, 2026
P/E ratio
27.89
52-wk high
$81.92
52-wk low
$51.91
EPS
$2.14
Beta
0.72
Shares outstanding
48.51M
No. of employees
1K
Open
$59.53
High
$60.34
Low
$59.03
Mkt. cap
2.90B
Avg. vol.
545.97K
Volume
205.69K
Dividend
2.07%
Quarterly dividend
$0.31
Ex-dividend date
Jun 5, 2026
P/E ratio
27.89
52-wk high
$81.92
52-wk low
$51.91
EPS
$2.14
Beta
0.72
Shares outstanding
48.51M
No. of employees
1K
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to EXPO in the past 3 months
Strong Buy
Buy
3
Hold
1
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for EXPO in the last 3 months.
Highest
Current $59.77
$80.00 (+33.85%)
Average
$73.96 (+23.74%)
Lowest
$66.89 (+11.91%)
News stories
From sources across the web
Profile
Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas. Wikipedia
About Exponent Inc
CEOCatherine Ford Corrigan
Employees1.01K
FoundedApr 1967
HeadquartersMenlo Park, California, United States
SectorService
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.59 / $0.62
-4.23%miss
Revenue / Est. (USD)
151.82M / 153.02M
-0.79%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
132.87M
137.07M
129.38M
151.82M
Cost of goods sold
97.47M
87.73M
80.89M
91.41M
Cost of revenue
97.47M
87.73M
80.89M
91.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.84M
11.56M
10.53M
10.30M
Operating expense
18.22M
20.31M
19.35M
19.03M
Total operating expenses
115.69M
108.04M
100.24M
110.44M
Operating income
17.18M
29.04M
29.14M
41.38M
Other non operating income
17.29M
7.27M
3.19M
-758.00K
EBT including unusual items
36.82M
38.62M
34.10M
42.34M
EBT excluding unusual items
36.82M
38.62M
34.10M
42.34M
Income tax expense
10.26M
10.57M
9.34M
12.77M
Effective tax rate
27.87%
27.38%
27.39%
30.16%
Other operating expenses
8.38M
8.75M
8.82M
8.73M
Net income
26.55M
28.04M
24.76M
29.57M
Net profit margin
19.98%
20.46%
19.14%
19.48%
Earnings per share
0.52
0.55
0.49
0.59
Interest and investment income
2.34M
2.31M
1.94M
1.72M
Interest expense
-
-
-
-
Net interest expenses
2.34M
2.31M
1.94M
1.72M
Depreciation and amortization charges
-
-
-
-
EBITDA
19.70M
31.57M
31.68M
43.89M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more